くすりのしおり

Injection
Revised: 2/2015

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
BOSMIN INJECTION 1mg [for ophthalmic use]
 Active ingredient:
Adrenaline
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine contracts iris muscles and causes mydriasis.
It is usually used to prevent adhesion of iris in patients with iridocyclitis.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have predisposition of increased intraocular pressure.
    If you have arteriosclerosis, hyperthyroidism, diabetes mellitus, arrhythmia, psychoneurosis, addiction to cocaine, heart disease, hypertension or lung emphysema.
    If you are receiving spinal anesthesia.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, apply to your eyes or inject subconjunctivally.
  • The treatment period with this medicine depends on your response to the treatment.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include pigmentation of eyelids or conjunctiva (during long-term use), nasolacrimal duct obstruction due to pigmentation (during long-term use), edema of macular region (during continuous use to patients with aphakic eyes), minor bleeding (during continuous use to patients with aphakic eyes), vasospasm (during continuous use to patients with aphakic eyes) and general symptoms. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • abnormal increased blood pressure, palpitation after exercise, respiratory distress, orthopnea (easy breathing in upright position than when lying down), nausea  [pulmonary edema]
  • respiratory difficulty, respiratory difficulty on exertion [respiratory distress]
  • tachycardia, arrhythmia, palpitations, chest anguish, cardiac arrest [cardiac arrest]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z